Ignite Creation Date:
2024-05-06 @ 7:24 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06008756
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-08-17
Brief Title:
Enlicitide Decanoate MK-0616 Oral PCSK9 Inhibitor Cardiovascular Outcomes Study MK-0616-015 CORALreef Outcomes
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hypercholesterolaemia |
| Arteriosclerosis |
Keywords: